# A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

> **NCT01264133** · PHASE4 · TERMINATED · sponsor: **Bukwang Pharmaceutical** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Clevudine, Adefovir

## Key facts

- **NCT ID:** NCT01264133
- **Lead sponsor:** Bukwang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2013-06
- **Final completion:** 2014-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2014-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01264133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01264133, "A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01264133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*